Standard Biotools (LAB) Gross Profit (2010 - 2026)

Standard Biotools (LAB) has 17 years of Gross Profit data on file, last reported at $11.3 million in Q1 2026.

• On a quarterly basis, Gross Profit rose 2.34% year-over-year to $11.3 million in Q1 2026; TTM through Mar 2026 was $42.8 million, a 4.69% decrease from a year earlier, with the FY2025 full-year figure at $42.5 million, down 5.21% from the prior year.
• Gross Profit for Q1 2026 stood at $11.3 million, down from $11.4 million in the prior quarter.
• Over the last five years, Gross Profit for LAB reached as high as $24.6 million in Q1 2022 and fell as low as $4.4 million in Q2 2022.
• Historically, Gross Profit has averaged $12.5 million across 5 years, with a median of $11.3 million in 2026.
• Across the five-year window, Gross Profit tumbled 92.6% in 2022 and soared 207.25% in 2023, its largest moves.
• Year by year, Gross Profit stood at $11.2 million in 2022, then climbed by 19.61% to $13.4 million in 2023, then retreated by 14.97% to $11.4 million in 2024, then rose by 0.22% to $11.4 million in 2025, then retreated by 0.65% to $11.3 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $11.3 million in Q1 2026, $11.4 million in Q4 2025, and $9.5 million in Q3 2025.